AR013096A1 - Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma. - Google Patents

Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.

Info

Publication number
AR013096A1
AR013096A1 ARP980102925A ARP980102925A AR013096A1 AR 013096 A1 AR013096 A1 AR 013096A1 AR P980102925 A ARP980102925 A AR P980102925A AR P980102925 A ARP980102925 A AR P980102925A AR 013096 A1 AR013096 A1 AR 013096A1
Authority
AR
Argentina
Prior art keywords
tetrazol
methyl
preparation
maleic acid
tetrahidropiridina
Prior art date
Application number
ARP980102925A
Other languages
English (en)
Spanish (es)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of AR013096A1 publication Critical patent/AR013096A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP980102925A 1997-07-01 1998-06-18 Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma. AR013096A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK78197 1997-07-01

Publications (1)

Publication Number Publication Date
AR013096A1 true AR013096A1 (es) 2000-12-13

Family

ID=8097489

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980102925A AR013096A1 (es) 1997-07-01 1998-06-18 Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.

Country Status (25)

Country Link
EP (1) EP0994869A1 (ko)
JP (1) JP2002507215A (ko)
KR (1) KR20010014297A (ko)
CN (1) CN1261361A (ko)
AR (1) AR013096A1 (ko)
AU (1) AU735751B2 (ko)
BG (1) BG103933A (ko)
BR (1) BR9810331A (ko)
CA (1) CA2293324A1 (ko)
CO (1) CO4940483A1 (ko)
EA (1) EA200000081A1 (ko)
HU (1) HUP0002876A2 (ko)
IL (1) IL133093A0 (ko)
IS (1) IS5278A (ko)
JO (1) JO2031B1 (ko)
MA (1) MA25138A1 (ko)
NO (1) NO996580L (ko)
PE (1) PE116099A1 (ko)
PL (1) PL337184A1 (ko)
SK (1) SK187399A3 (ko)
TN (1) TNSN98120A1 (ko)
TR (1) TR199903283T2 (ko)
UY (2) UY25069A1 (ko)
WO (1) WO1999001448A1 (ko)
ZA (1) ZA985498B (ko)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714789D0 (en) * 1987-06-24 1987-07-29 Lundbeck & Co As H Heterocyclic compounds
TR199800801T2 (xx) * 1995-11-06 1998-08-21 H. Lund-Beck A/S Travmatik beyin yaralanmalar�n�n tedavisi.

Also Published As

Publication number Publication date
PE116099A1 (es) 1999-11-23
JP2002507215A (ja) 2002-03-05
CO4940483A1 (es) 2000-07-24
BG103933A (en) 2000-07-31
CA2293324A1 (en) 1999-01-14
IS5278A (is) 1999-11-30
SK187399A3 (en) 2000-06-12
NO996580D0 (no) 1999-12-30
HUP0002876A2 (hu) 2001-06-28
CN1261361A (zh) 2000-07-26
TR199903283T2 (xx) 2000-06-21
AU735751B2 (en) 2001-07-12
AU8102098A (en) 1999-01-25
NO996580L (no) 1999-12-30
JO2031B1 (en) 1999-05-15
BR9810331A (pt) 2000-09-05
MA25138A1 (fr) 2001-04-02
PL337184A1 (en) 2000-08-14
EP0994869A1 (en) 2000-04-26
UY25069A1 (es) 1998-12-21
WO1999001448A1 (en) 1999-01-14
UY25177A1 (es) 2000-12-29
EA200000081A1 (ru) 2000-08-28
ZA985498B (en) 1999-01-20
IL133093A0 (en) 2001-03-19
KR20010014297A (ko) 2001-02-26
TNSN98120A1 (fr) 2005-03-15

Similar Documents

Publication Publication Date Title
DE69017302D1 (de) Zentrale Cholecystokinin-Antagonisten zur Behandlung von psychiatrischen Krankheiten.
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
MY128654A (en) Liquid pharmaceutical composition containing an erythropoietin derivative
ATE225341T1 (de) In 6-position durch thio substituierte paclitaxele
BR9714517A (pt) Cicloalquila, lactama, lactona e compostos correlatos, composições farmacêuticas compreendendo os mesmos e processos para inibir liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos
DK0495982T3 (da) Bicyklisk pyrimidinderivat, fremgangsmåde til fremstilling deraf og farmaceutisk præparat omfattende dette som en aktiv bestanddel
BG101118A (en) Therapeutical compounds
BRPI0007487B8 (pt) difenil-uréias substituídas com w-carbóxi-arilas como inibidores de raf cinase
BR9714059A (pt) S-omeprazol em uma forma neutra, processo para preparar o mesmo, uso deste, composição farmacêutica, e, processo para tratar uma condição relacionada com ácido gástrico.
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
ES2149276T3 (es) Imidazo(4,5-c)piridin-4-aminas.
BRPI0416752A (pt) composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica
PT100850A (pt) Composicoes farmaceuticas contendo uma mistura sinergica de um agente uricosurico, em especial,de probenecid, com um agente antagonista de aminoacidos excitantes, em especial,um derivado de quinoxalina substituido e sua utilizacao no tratamento de doencas neurodegenerativas
KR870700599A (ko) 카르복실산유도체, 그의 제조방법, 이화합물을 함유한 약제조성물 및 그의 용도
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
BR0009524A (pt) Uso de um composto, e, composição farmacêutica ou veterinaria
BRPI0409884A (pt) compostos, composições farmacêuticas, método para o tratamento ou porfilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
EP0974363A4 (en) REMEDIES FOR ADDICTION
BR9809234A (pt) Composto, composição farmacêutica, uso de um composto, processos para tratar ou prevenir doenças do sistema endocrinológico, para fabricar um medicamento, para preparar um composto e um conjunto, conjunto, e, uso do mesmo.
BRPI0409818A (pt) compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
AR013096A1 (es) Sal de adicion de acido maleico de 5-(2-etil-2-h-tetrazol-5-il)-1-metil- 1,2,3,6-tetrahidropiridina, composicion farmaceutica que la contiene, su usoen terapia y metodo de preparacion de la misma.
DK52080A (da) Dehydropeptider fremgangsmaader til deres fremstilling samt deres anvendelse som laegemidler
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
NO965370L (no) Substituerte kromanylsulfonyl(tio)ureaer, fremgangsmåter til deres fremstilling, deres anvendelse i farmasöytiske preparater samt farmasöytiske preparater inneholdende forbindelsene
IT1265647B1 (it) Composizione farmaceutiche topiche per le allergie respiratorie

Legal Events

Date Code Title Description
FA Abandonment or withdrawal